Cargando…
L-Type amino acid transporter 1 as a target for drug delivery
Our growing understanding of membrane transporters and their substrate specificity has opened a new avenue in the field of targeted drug delivery. The L-type amino acid transporter 1 (LAT1) has been one of the most extensively investigated transporters for delivering drugs across biological barriers...
Autores principales: | Puris, Elena, Gynther, Mikko, Auriola, Seppo, Huttunen, Kristiina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203094/ https://www.ncbi.nlm.nih.gov/pubmed/32377929 http://dx.doi.org/10.1007/s11095-020-02826-8 |
Ejemplares similares
-
Targeting Transporters for Drug Delivery to the Brain: Can We Do Better?
por: Puris, Elena, et al.
Publicado: (2022) -
Alzheimer’s Disease Phenotype or Inflammatory Insult Does Not Alter Function of L-Type Amino Acid Transporter 1 in Mouse Blood-Brain Barrier and Primary Astrocytes
por: Gynther, Mikko, et al.
Publicado: (2018) -
l-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
por: Huttunen, Johanna, et al.
Publicado: (2019) -
The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
por: Puris, Elena, et al.
Publicado: (2023) -
L-Type Amino Acid Transporter 1-Utilizing Prodrugs of Ketoprofen Can Efficiently Reduce Brain Prostaglandin Levels
por: Montaser, Ahmed, et al.
Publicado: (2020)